Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Bril

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
Frontiers in Endocrinology|February 5, 2025
Glucagon-like peptide-1 receptor agonists and type 1 diabetes: a potential game changer?Ortal Resnick, Fernando Bril, Giovanna Beauchamp
Liver International : Official Journal of the International Association for the Study of the Liver|August 17, 2024
Metabolic characteristics of patients with MetALD: Caveats of a new definitionErin Petrie, Meagan Gray, Fernando Bril
Thyroid : Official Journal of the American Thyroid Association|January 18, 2019
Re: "Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis" by Mantovani et al. (Thyroid 2018;28:1270-1284)Fernando Bril, Sushma Kadiyala, Kenneth Cusi
JAMA Network Open|March 18, 2026
Liver Stiffness Measurement and All-Cause Mortality in Individuals With DiabetesFernando Bril, Ky Huynh, Parameshwara Rao Bolla
JCEM Case Reports|November 12, 2025
Risk of Euglycemic Diabetic Ketoacidosis Can Persist After Discontinuation of Sodium-glucose Cotransporter-2 InhibitorsSai Sumedha Bobba, Elizabeth Campbell, Fernando Bril
Trends in Endocrinology and Metabolism: TEM|December 18, 2016
Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment StrategiesNishanth E Sunny, Fernando Bril, Kenneth Cusi
Journal of the Endocrine Society|July 2, 2025
Prevalence of MASLD in People With Diabetes Has Decreased in the US, but Rates of Liver Fibrosis Are Still on the RiseFernando Bril, Parameshwara Bolla, Ky Huynh, et al.
Diabetes, Obesity & Metabolism|December 10, 2022
Pioglitazone discontinuation in patients with nonalcoholic steatohepatitis is associated with disease recurrenceFernando Bril, Srilaxmi Kalavalapalli, Romina Lomonaco, et al.
Current Drug Safety|March 10, 2010
Antimicrobial agents-associated with QT interval prolongationFernando Bril, Claudio Daniel Gonzalez, Guillermo Di Girolamo
The Journal of Clinical Endocrinology and Metabolism|March 9, 2019
Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 DiabetesDiana Barb, Fernando Bril, Srilaxmi Kalavalapalli, et al.
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Frontiers in Endocrinology|February 5, 2025
Glucagon-like peptide-1 receptor agonists and type 1 diabetes: a potential game changer?Ortal Resnick, Fernando Bril, Giovanna Beauchamp
Liver International : Official Journal of the International Association for the Study of the Liver|August 17, 2024
Metabolic characteristics of patients with MetALD: Caveats of a new definitionErin Petrie, Meagan Gray, Fernando Bril
Thyroid : Official Journal of the American Thyroid Association|January 18, 2019
Re: "Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis" by Mantovani et al. (Thyroid 2018;28:1270-1284)Fernando Bril, Sushma Kadiyala, Kenneth Cusi
JAMA Network Open|March 18, 2026
Liver Stiffness Measurement and All-Cause Mortality in Individuals With DiabetesFernando Bril, Ky Huynh, Parameshwara Rao Bolla
JCEM Case Reports|November 12, 2025
Risk of Euglycemic Diabetic Ketoacidosis Can Persist After Discontinuation of Sodium-glucose Cotransporter-2 InhibitorsSai Sumedha Bobba, Elizabeth Campbell, Fernando Bril
Trends in Endocrinology and Metabolism: TEM|December 18, 2016
Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment StrategiesNishanth E Sunny, Fernando Bril, Kenneth Cusi
Journal of the Endocrine Society|July 2, 2025
Prevalence of MASLD in People With Diabetes Has Decreased in the US, but Rates of Liver Fibrosis Are Still on the RiseFernando Bril, Parameshwara Bolla, Ky Huynh, et al.
Diabetes, Obesity & Metabolism|December 10, 2022
Pioglitazone discontinuation in patients with nonalcoholic steatohepatitis is associated with disease recurrenceFernando Bril, Srilaxmi Kalavalapalli, Romina Lomonaco, et al.
Current Drug Safety|March 10, 2010
Antimicrobial agents-associated with QT interval prolongationFernando Bril, Claudio Daniel Gonzalez, Guillermo Di Girolamo
The Journal of Clinical Endocrinology and Metabolism|March 9, 2019
Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 DiabetesDiana Barb, Fernando Bril, Srilaxmi Kalavalapalli, et al.
Pageof 10